Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBerkeley Eng Regulatory News (BKY)

Share Price Information for Berkeley Eng (BKY)

Share Price is delayed by 15 minutes
Get Live Data
24.50    -0.80 (-3.16%)
Bid:
24.00
Ask:
25.00
Spread: 1.00 (4.167%)
Market Cap: £109.34m
BKY Live PriceLast checked at - London Stock Exchange

Intraday Berkeley Eng Share Chart

Permitting Update

23 Jul 2021 08:29

RNS Number : 2721G
Berkeley Energia Limited
23 July 2021
 

BERKELEY ENERGIA LIMITED

 

NEWS RELEASE | 23 July 2021

 

Permitting Update

 

Berkeley Energia Limited ("Berkeley" or the "Company") advises that it has taken the first steps to overturn the previously announced unfavorable decision by the Nuclear Safety Council ("NSC") for the grant of the Authorisation for Construction for the uranium concentrate plant as a radioactive facility ("NSC II") at the Company's Salamanca project (see announcement dated 12 July 2021).

 

Berkeley has now submitted an 'Improvement Report' to supplement the Company's initial NSC II Application, along with the corresponding arguments that address all of the issues raised by the NSC, and has requested its reassessment by the NSC. The Improvement Report includes technical arguments that, in the Company's view, will clearly demonstrate that the project is compliant with all requirements for NSC II.

 

This Improvement Report and associated documentation has been submitted to the Ministry of Ecological Transition and Demographic Challenge ("MITECO") following its notification to the Company advising that, in accordance with Spanish administrative law, a hearing process in relation to the NSC's decision has been opened and provides Berkeley with the opportunity to submit relevant documentation to MITECO by 4 August 2021.

 

As previously reported, Berkeley strongly refutes the NSC's assessment and notes that all documentation submitted by the Company in relation to NCS II has been prepared following advice from independent, nationally and internationally recognised advisors and consultants who are experts in their field.

 

It should also be noted that more than 120 previous permits and favourable reports have been granted by the relevant authorities at the local, regional, federal and European Union levels in relation to the Salamanca project, among which nine have been from the NSC.

 

The Company will continue to strongly defend its position in relation to the adverse decision by the NSC and will continue to update the market on any material developments as they occur.

 

 

For further information please contact:

Robert Behets Francisco Bellón

Acting Managing Director Chief Operations Officer

+61 8 9322 6322 +34 91 555 1380

info@berkeleyenergia.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDFIFFDDRIVFIL
Date   Source Headline
4th Jan 20229:01 amRNSPrice Monitoring Extension
31st Dec 20217:00 amRNSReport on Payments to Govts
30th Nov 20217:00 amRNSConversion of Convertible Note
29th Nov 20219:05 amRNSSecond Price Monitoring Extn
29th Nov 20219:00 amRNSPrice Monitoring Extension
29th Nov 20217:00 amRNSPermitting Update
17th Nov 20217:00 amRNSResult of AGM
5th Nov 20217:00 amRNSOIA Claim
3rd Nov 20214:40 pmRNSSecond Price Monitoring Extn
3rd Nov 20214:35 pmRNSPrice Monitoring Extension
3rd Nov 20212:06 pmRNSSecond Price Monitoring Extn
3rd Nov 20212:00 pmRNSPrice Monitoring Extension
2nd Nov 20212:05 pmRNSSecond Price Monitoring Extn
2nd Nov 20212:00 pmRNSPrice Monitoring Extension
2nd Nov 20217:16 amRNSASX Trading Halt
29th Oct 20217:00 amRNSQuarterly Report September 2021
26th Oct 20217:00 amRNSResignation of Director
12th Oct 20217:00 amRNSNotice of AGM
17th Sep 20217:50 amRNSDate of Annual General Meeting
31st Aug 20217:00 amRNSAnnual Report to shareholders
5th Aug 20217:28 amRNSPermitting Update
30th Jul 20217:00 amRNSQuarterly Report June 2021
23rd Jul 20218:29 amRNSPermitting Update
16th Jul 202111:05 amRNSSecond Price Monitoring Extn
16th Jul 202111:00 amRNSPrice Monitoring Extension
15th Jul 20214:40 pmRNSSecond Price Monitoring Extn
15th Jul 20214:35 pmRNSPrice Monitoring Extension
13th Jul 202111:05 amRNSSecond Price Monitoring Extn
13th Jul 202111:00 amRNSPrice Monitoring Extension
13th Jul 20219:05 amRNSSecond Price Monitoring Extn
13th Jul 20219:00 amRNSPrice Monitoring Extension
12th Jul 20214:41 pmRNSSecond Price Monitoring Extn
12th Jul 20214:35 pmRNSPrice Monitoring Extension
12th Jul 20212:05 pmRNSSecond Price Monitoring Extn
12th Jul 20212:00 pmRNSPrice Monitoring Extension
12th Jul 20211:45 pmRNSPermitting Update
25th Jun 20218:29 amRNSAdmission of shares to trading
20th May 20212:05 pmRNSSecond Price Monitoring Extn
20th May 20212:00 pmRNSPrice Monitoring Extension
14th May 20217:00 amRNSUpdate on Spanish Regulatory Regime
29th Apr 20217:00 amRNSQuarterly Report March 2021
9th Apr 20217:00 amRNSUpdate on Spanish Regulatory Regime
26th Mar 20217:00 amRNSIssue of shares on exercise of unlisted options
10th Mar 20217:00 amRNSHalf-year Report
25th Feb 20214:41 pmRNSSecond Price Monitoring Extn
25th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20214:41 pmRNSSecond Price Monitoring Extn
24th Feb 20214:35 pmRNSPrice Monitoring Extension
24th Feb 20212:06 pmRNSSecond Price Monitoring Extn
24th Feb 20212:01 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.